Chapter 11
Co-Occurring Substance Use and Mental Health Disorders:
A Social Justice Perspective
Chapter Overview
This chapter examines co-occurring substance use and mental health disorders through a social justice lens, emphasizing the necessity of centering the individual within the context of larger societal structures. Recognizing the profound significance of these co-occurring conditions, the paper argues for an integrated approach to practice that encompasses both micro and macro considerations and interventions. We begin by providing an overview of co-occurring disorders and their urgency. Next, we conceptualize these disorders from a human rights and social justice framework, asserting that an integrated approach grounded in human rights must prioritize these rights over other policy outcomes. This human rights-based perspective is essential for securing equal access to comprehensive care. The paper advocates an integrated system of care guided by evidence-based approaches, and implementing a ‘no wrong door’ model that centers the person within the treatment system and structural context. The chapter concludes with key practice and policy considerations that reflect the individual’s integrated and interactive ecosystem. It calls for collective action among system leaders, regulators, and funders to develop and sustain an integrated system, ensuring that individuals with co-occurring disorders are better served and granted the opportunity to develop a full life.
Reflective Questions
Designed to encourage critical thinking, real-world application, and meaningful discussion.
- Why have mental health and substance use systems historically operated separately?
- What are the clinical and ethical consequences of service fragmentation?
- How does stigma toward substance use differ from stigma toward mental illness?
Resource Connect
Links to professional standards, policy frameworks, and cross-referenced chapters that support deeper exploration.content.
SAMHSA: Treatment for People With Co-Occurring Disorders
Substance Abuse and Mental Health Services Administration. (2020). Substance Use Disorder Treatment for People With Co-Occurring Disorders (Treatment Improvement Protocol 42). TIP 42 provides guidance on screening, assessment, diagnosis, treatment planning, medication, trauma-informed care, recovery support, and service coordination for people with co-occurring mental health and substance use disorders. It emphasizes treating the person as a whole rather than requiring clients to move between separate and poorly coordinated systems.
SAMHSA Integrated Treatment for Co-Occurring Disorders Toolkit
SAMHSA’s Integrated Treatment for Co-Occurring Disorders Evidence-Based Practices Kit provides implementation principles, program-development materials, assessment tools, and guidance for interdisciplinary teams. The model combines mental-health and substance-use treatment within one coordinated program and incorporates motivational approaches, staged interventions, recovery planning, and long-term community support.
United States Interagency Council on Homelessness: Housing First Resources
The United States Interagency Council on Homelessness provides research summaries, implementation guidance, and an organizational checklist for evaluating whether housing programs follow Housing First principles. Housing First does not make sobriety, psychiatric stabilization, or completion of treatment prerequisites for obtaining housing. Instead, permanent housing is paired with voluntary, person-centered health, behavioral-health, and community supports. These resources can help students examine housing as a social determinant of mental health and recovery rather than as a reward for treatment compliance.
CDC Drug-Overdose and Harm-Reduction Data
The Centers for Disease Control and Prevention maintains several complementary data systems. The National Center for Health Statistics provides provisional overdose-death counts; the State Unintentional Drug Overdose Reporting System provides detailed information about fatal overdoses; and the DOSE dashboards track nonfatal overdoses treated in emergency departments and hospitals. Students can compare trends by substance, location, demographic group, and type of overdose while considering the limitations of provisional and surveillance data.
Legislative Analysis and Public Policy Association
The Legislative Analysis and Public Policy Association conducts legal and legislative research concerning substance use, overdose prevention, treatment, recovery, harm reduction, public safety, and the criminal-legal system. Its model laws and state-policy materials address such subjects as naloxone access, medications for opioid use disorder, opioid-settlement funds, treatment in correctional settings, recovery housing, workforce development, and overdose-fatality review. These materials allow students to compare treatment-oriented, harm-reduction, and punitive policy responses.
Cross-reference: See Chapter 6 Mental Health with Justice-Impacted Individuals for discussion of criminalization, correctional treatment, diversion, reentry, and continuity of care; and Chapter 12 Structural Racism and Community Mental Health: Barriers to Treatment and Access for analysis of racial disparities, institutional exclusion, neighborhood conditions, unequal treatment access, and the social distribution of substance-related harms.
Further Resources
Suggested readings, research areas, and materials for extended learning.
Integrated Treatment for Co-Occurring Disorders
Chetty, A., Guse, T., & Malema, M. (2023). Integrated vs. non-integrated treatment outcomes in dual diagnosis disorders: A systematic review. Health SA Gesondheid, 28, Article 2094.
This review compares integrated and non-integrated interventions for people with mental health and substance use disorders. It supports coordinated treatment while also identifying variation in interventions, outcomes, populations, and research quality.
Kikkert, M., Goudriaan, A., de Waal, M., Peen, J., & Dekker, J. (2018). Effectiveness of Integrated Dual Diagnosis Treatment in severe mental illness outpatients with a co-occurring substance use disorder. Journal of Substance Abuse Treatment, 95, 35–42.
This randomized implementation study found a reduction in days of alcohol or drug use following implementation of Integrated Dual Diagnosis Treatment, but it did not find improvement across all clinical and functional outcomes. It provides a useful basis for discussing the difference between identifying an evidence-based model and implementing that model effectively in routine community practice.
Integrated treatment should not be presented simply as placing two services in the same building. Genuine integration requires shared assessment, coordinated treatment planning, communication across disciplines, attention to psychiatric and substance-related symptoms at the same time, and agreement that clients will not be rejected from one system because they also require assistance from another.
Housing First and Housing Stability
Tsemberis, S., Gulcur, L., & Nakae, M. (2004). Housing First, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. American Journal of Public Health, 94(4), 651–656.
This foundational study examines a Housing First program for people experiencing homelessness who had serious mental-health and substance-use needs. It challenges the assumption that people must demonstrate treatment compliance or abstinence before they can successfully maintain independent housing.
Housing First research should be interpreted carefully. The model has strong evidence for improving housing stability, but stable housing does not automatically eliminate substance use, psychiatric symptoms, poverty, trauma, or the need for accessible treatment. Housing should therefore be understood as a necessary foundation for recovery rather than a complete clinical intervention.
Harm-Reduction Outcomes
Mackey, K. M., Beech, E. H., Williams, B. E., Anderson, J. K., Young, S., & Parr, N. J. (2023). Effectiveness of Syringe Services Programs: A Systematic Review. U.S. Department of Veterans Affairs, Evidence Synthesis Program.
The review examines evidence concerning HIV and hepatitis C transmission, injection practices, naloxone and overdose education, connections to treatment, syringe disposal, and neighborhood crime. It concludes that the overall evidence supports syringe-service implementation while acknowledging methodological limitations in studies of complex community interventions.
Fischer, L. S., Asher, A., Stein, R., Becasen, J., Doreson, A., et al. (2025). Effectiveness of naloxone distribution in community settings to reduce opioid-overdose deaths among people who use drugs: A systematic review and meta-analysis. BMC Public Health, 25, Article 1135.
This review evaluates overdose education and naloxone-distribution programs across community settings. It provides evidence supporting expanded community access to naloxone while illustrating the challenges involved in connecting individual overdose reversals to population-level mortality trends.
Harm reduction does not require indifference to substance use or abandonment of recovery goals. It begins with the recognition that people deserve protection from preventable death, infectious disease, injury, homelessness, incarceration, and stigma regardless of whether they are currently abstinent or engaged in formal treatment.
Overdose Surveillance and Public-Health Trends
The CDC’s provisional overdose-death dashboard, SUDORS fatal-overdose dashboard, and DOSE nonfatal-overdose dashboards should be used for current data rather than placing rapidly changing national statistics in static teaching materials. Students should examine distinctions among fatal and nonfatal overdose, opioid and stimulant involvement, demographic disparities, geographic variation, and the difference between provisional and finalized data.
An effective classroom discussion should avoid treating overdose trends as evidence of individual failure. Overdose patterns are shaped by drug-supply toxicity, treatment availability, housing instability, healthcare access, poverty, stigma, criminalization, community resources, and access to naloxone and other harm-reduction services.
Substance-Use Policy and Reform
Smart, R., Pardo, B., & Davis, C. S. (2021). Systematic review of the emerging literature on the effectiveness of naloxone-access laws in the United States. Addiction, 116(1), 6–17.
The review found that naloxone-access laws were generally associated with increased naloxone availability, although evidence concerning their effects on fatal-overdose rates was less consistent. It demonstrates why policy evaluation must examine the specific provisions, implementation, funding, and local context of a law rather than simply whether a law exists.
The White House Office of National Drug Control Policy and the Legislative Analysis and Public Policy Association provide model state laws concerning overdose-reversal agents, medications for opioid use disorder, opioid-litigation proceeds, treatment in correctional settings, workforce development, and recovery supports. These materials can be used to compare public-health policies with approaches centered on surveillance, punishment, or incarceration.
Policy analysis should consider not only whether a reform has been enacted but also who can access it, whether it is adequately funded, how it is implemented, whether racial and geographic disparities persist, and whether people with lived experience participated in its development.